Pharmafile Logo

Inizio

Inizio is your market-leading commercialization partner.

We provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Leveraging our connected suite of capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle, creating solutions that simplify the complex, unlock value, and enhance treatment outcomes.

6th Floor, Holborn Gate, 26 Southampton Buildings, WC2A 1AN United Kingdom

At the heart of our success are the talented experts who work hand-in-hand with our clients to deliver exceptional value, innovation, and impact. Explore our latest awards, achievements, and recognitions as we continue to set new standards and reimagine the future of health here.

 

With >10,500 specialists across >50 countries, we unite global reach with deep, broad expertise in science, strategy, creativity, and technology. Our work spans all 14 therapeutic areas, and we’re proud to support every one of the top 20 pharmaceutical companies worldwide. What sets us apart is how we bring our capabilities together, across five areas of our business:

 

Inizio Ignite

Inizio Ignite is the global advisory partner for health and life sciences, encompassing connected expertise across Research Partnership, Putnam, Vynamic, and STEM. We collaborate with you to ignite impact, accelerate performance, and deliver lasting change for patients.  

Inizio Medical

Inizio Medical connects scientific expertise and technology to create compelling content and experiences that inform, inspire, and engage medical communities globally.

Inizio Medical brings together three of the most recognized and trusted global medical communications agencies – ApotheCom, Ashfield MedComms and Nucleus Global –  underpinned with best-in-class Medical Affairs consulting, data analytics, integrated evidence generation, and industry-leading AI solutions through medical excellence and transformation agency, MEDiSTRAVA.

 

Inizio Evoke

Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insight and human centricity.

Inizio Evoke – a full-service team of creative problem solvers who always find a way to make health more human™ – is built to design intuitive, people-centric experiences, brands, and businesses that drive transformative growth across brand and creative, communications, transformation, access, and media.

 

Inizio Engage

Inizio Engage is a global strategic, commercial, and creative engagement partner.

Combining a unique mix of consultation, creation, and activation expertise with the latest technology, Inizio Engage design and deliver tailored solutions that inspire lasting change across decision optimization, experience design (XD), patient solutions, Medical Affairs, and commercial.

 

Inizio Biotech

Inizio Biotech develops personalized solutions curated to maxmise asset value at every opportunity.

Providing best-in-class services across the clinical development and commercialization journey, our biotech solutions are highly personalized and coordinated through a single strategic point of contact. Inizio Biotech support you by guiding, validating, and inspiring the decisions that matter most.

‘Smear Word’ campaign for Roche aims to break taboos and save lives

An all-female team at Mind+Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test.

Research Partnership’s MedTech Division appoints two Directors

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Quantitative specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London

CRYOPORT APPOINTS MIND+MATTER AS PART OF A GLOBAL BRAND DEVELOPMENT TENDER

Cryoport Inc has appointed creative communications agency Mind+Matter, an Ashfield Health company, part of UDG Healthcare as its strategic marketing partner to support the rebrand of the entire business alongside...

Ashfield Healthcare Communications rebrands as Ashfield Health

Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.

A MERGER THAT MATTERS

Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter     ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness   New global agency offers 24/7 access...

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Pegasus expands Pharma team with senior hires

Five new recruits support further growth of the Pharma & Life Sciences team

GENERATION Z IS FEARFUL FOR THE FUTURE OF UK HEALTH SERVICES, SAYS NEW REPORT

A comprehensive study into the health attitudes and behaviours of Generation Z shows an overwhelming concern by our youngest voting generation that health services won’t meet their needs or expectations...

PEGASUS WINS AT PHARMATIMES COMMUNICATIONS TEAM OF THE YEAR AWARDS 2018

Pegasus was also highly commended in the NHS Communications Team category

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

Four steps to a smarter congress strategy: A practical guidebook

This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Infographic: Are data blind spots putting your launch at risk?

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize...

Key takeaways from ASCO® 2026

Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

From activity to impact: 5 takeaways from MAPS Americas 2026

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now...

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize...

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Reimagine health with Inizio.

At Inizio, we provide tailored, innovative solutions to help health and life sciences companies with their clinical development and commercialization journeys, maximizing patient access. Our experts guide you through each...

What we do and who we do it for | Pegasus

We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital...

Understanding decision making in health | Pegasus

To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy...

An animated approach to communicating healthy messages | Pegasus

Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within...

At Inizio, sustainability means minimizing our environmental impact, championing inclusion, promoting health equity, and operating in a responsible, ethical manner that allows us to grow in a way that benefits all our stakeholders.

Guided by our Commitments, our people are empowered to make a real difference. In our latest report, we’re proud to present the significant progress we made in 2024. Read our 2024 Sustainability Report. 

Ryan Quigley

Ryan Quigley
CEO, Inizio

Gavin McShera

Gavin McShera
Chief Information Officer, Inizio

Mary-Kate McGarry

Mary-Kate McGarry
Chief Strategy & Innovation Officer, Inizio

Ben Jackson

Ben Jackson
CFO, Inizio

Colin Stanley

Colin Stanley
CCO, Inizio

Grainne McAleese

Grainne McAleese
Deputy CFO, Inizio

Remco op den Kelder

Remco op den Kelder
President, Inizio Ignite

Elaine Ferguson

Elaine Ferguson
Global President, Inizio Medical

Reid Connolly

Reid Connolly
Global President, Inizio Evoke

Jim Sage

Jim Sage
Global President, Inizio Engage

Company Details

 Latest Content from  Inizio 

Intelligent Commercialization™ across the pharma lifecycle

Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.

Four steps to a smarter congress strategy: A practical guidebook

This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.

Infographic: Are data blind spots putting your launch at risk?

Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…

Key takeaways from ASCO® 2026

Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…

Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026

Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.

From activity to impact: 5 takeaways from MAPS Americas 2026

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…

Inizio launches Intelligent Congress: Turning medical event investment into measurable impact

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.